Corpus Intelligence IC Memo — DELL CHILDRENS MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — DELL CHILDRENS MEDICAL CENTER
Investment Committee Memorandum | TX | 262 beds | Grade B | EBITDA uplift $66.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

DELL CHILDRENS MEDICAL CENTER

CCN 453310 | TRAVIS, TX | 262 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

DELL CHILDRENS MEDICAL CENTER is a 262-bed suburban community hospital in TRAVIS, TX with $901.9M in net patient revenue and a 25.5% operating margin. The hospital serves a payer mix of 0.4% Medicare, 5.6% Medicaid, and 94.0% commercial.

Thesis: Platform Growth. Our ML models identify $66.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.5% to 32.9% (+736bps).

Net Revenue HCRIS$901.9M
Current EBITDA COMPUTED$230.2M
Operating Margin COMPUTED25.5%
Occupancy HCRIS63.6%
Revenue / Bed COMPUTED$3.4M
Net-to-Gross HCRIS45.7%
Distress Probability ML43.2%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
135
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 25.5% places it above the state median. Among 135 size-comparable peers (131-524 beds), the median margin is 4.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (131-524), prioritizing same-state peers. 135 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DELL CHILDRENS MEDICAL CENTER (Target)TX262$901.9M25.5%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
COOK CHILDRENS MEDICAL CENTERTX423$1.51B16.5%
CHRISTUS MOTHER FRANCES HOSP-TTX518$971.6M-17.0%
DOCTORS HOSPITAL AT RENAISSANCTX394$847.8M9.2%
ASCENSION SETON MEDICAL CENTERTX391$702.5M12.6%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
METHODIST SUGAR LAND HOSPITALTX337$679.6M12.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $66.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$18.9M+210bp18mo
Cost to Collect4.5%2.5%$18.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$17.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$11.0M+122bp9mo
Clean Claim Rate88.0%96.0%$577K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$18.9M
Cost to Collect
$18.0M
Denial Rate Reduction
$17.9M
A/R Days Reduction
$11.0M
Clean Claim Rate
$577K
Total EBITDA Uplift$66.4M
Current EBITDA$230.2M
+ RCM Uplift+$66.4M
Pro Forma EBITDA$296.6M
Current Margin25.5%
Pro Forma Margin32.9%
WC Released (1x)$34.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$354.1M$2.18B6.16x43.9%
Base (11x exit)10.0x11.0x$354.1M$2.52B7.10x48.0%
Bull Case9.0x11.0x$318.7M$2.85B8.94x55.0%
Bull (12x exit)9.0x12.0x$318.7M$3.20B10.05x58.6%
Bear Case11.0x10.0x$389.5M$1.74B4.45x34.8%
Bear (11x exit)11.0x11.0x$389.5M$2.04B5.23x39.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 135 hospitals with 131-524 beds
  • Same-state prioritization (n=136)
  • Comp margins: P25=-7.9% / P50=4.5% / P75=13.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.